Display options
Cite
Dutta S, Chattopadhayay S, Dasgupta C, et al. Low molecular weight heparin: a practical approach in deep venous thrombosis in palliative care. Indian J Palliat Care. 2011;17(2):143-5doi: 10.4103/0973-1075.84536.
Dutta, S., Chattopadhayay, S., Dasgupta, C., & Sarkar, S. (2011). Low molecular weight heparin: a practical approach in deep venous thrombosis in palliative care. Indian journal of palliative care, 17(2), 143-5. https://doi.org/10.4103/0973-1075.84536
Dutta, Samrat, et al. "Low molecular weight heparin: a practical approach in deep venous thrombosis in palliative care." Indian journal of palliative care vol. 17,2 (2011): 143-5. doi: https://doi.org/10.4103/0973-1075.84536
Dutta S, Chattopadhayay S, Dasgupta C, Sarkar S. Low molecular weight heparin: a practical approach in deep venous thrombosis in palliative care. Indian J Palliat Care. 2011 May;17(2):143-5. doi: 10.4103/0973-1075.84536. PMID: 21976855; PMCID: PMC3183604.
Copy Download .nbib Format: NLM
Share it on

Indian J Palliat Care. 2011 May;17(2):143-5. doi: 10.4103/0973-1075.84536.

Low molecular weight heparin: a practical approach in deep venous thrombosis in palliative care.

Indian journal of palliative care

Samrat Dutta, Subrata Chattopadhayay, C Dasgupta, Shyamal Sarkar

Affiliations

  1. Department of Radiotherapy, Medical College and Hospital, Kolkata, India.

PMID: 21976855 PMCID: PMC3183604 DOI: 10.4103/0973-1075.84536

Abstract

INTRODUCTION: Deep vein thrombosis (DVT) is one of the many cause of pain in advance cases of carcinoma cervix. The most widely used agent for combating DVT is unfractionated heparin.

AIMS: Aims of this study is to see the efficacy of the use of low molecular weight (LMW) haparin and its practical utility in palliative care settings.

MATERIALS AND METHODS: Twelve cases of established DVT received enoxaparin at 40 mg/m with warfarin.

RESULTS: There was 70% resolution of limb swelling in seven cases. Out of remaining four cases took two months to resolve and one case did not resolve completely.

CONCLUSIONS: LMV heparin is effective in palliative care setting and also has added advantage of subcutaneous route of administration.

Keywords: Cervix; Heparin; Lymphedema

References

  1. Lancet. 1992 Feb 22;339(8791):441-5 - PubMed
  2. Chest. 2008 Jun;133(6 Suppl):340S-380S - PubMed
  3. Arch Intern Med. 1998 Sep 14;158(16):1809-12 - PubMed
  4. Haematologica. 2002 Mar;87(3):286-91 - PubMed
  5. Am J Med. 1996 Mar;100(3):269-77 - PubMed
  6. Arch Intern Med. 2000 Jan 24;160(2):181-8 - PubMed
  7. Thromb Haemost. 1999 Aug;82(2):947-52 - PubMed

Publication Types